title: Three months' administration of anti-IgE to a patient with Churg-Strauss syndrome.
authors.forename: Pedro
authors.initials: P
authors.lastname: Giavina-Bianchi
authors.forename: Mara
authors.initials: M
authors.lastname: Giavina-Bianchi
authors.forename: Rosana
authors.initials: R
authors.lastname: Agondi
authors.forename: Jorge
authors.initials: J
authors.lastname: Kalil
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D015267:Churg-Strauss Syndrome / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab; D013997:Time Factors
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E